SCHEMA 3 — CONSULTATIVE DIALOGUE

Conversation-Driven
Clinical Encounter

The patient tells the story. You guide the conversation.

How This Works

This assessment simulates a real clinical dialogue. The patient responds to your questions and tone. What you ask—and how you ask it—determines what information you receive. Optional resources (colleague consult, drug reference) are available at any time without penalty.

Patient arriving shortly...
Clinical Encounter
Opening
ENCOUNTER COMPLETE

Encounter Summary

Key Takeaways
    Back to Schema Overview
    Colleague Consult

    Dr. Reeves, Infectious Disease: "For uncomplicated UTI in female patients, a fluoroquinolone or nitrofurantoin is typically first-line. But always check for drug interactions—especially CYP3A4 inhibitors like macrolide antibiotics. If the patient recently stopped a macrolide, the inhibitory effect can persist for several days after the last dose. Timing matters. Also, make sure you ask about medication adherence. Patients will sometimes discontinue antibiotics early due to side effects, and that context changes your prescribing calculus."

    Resource — no scoring impact
    Drug Reference

    Methenamine hippurate (Hiprex)

    Indication: Urinary tract infection (prophylaxis and treatment of chronic/recurrent UTI)

    Standard dosing: 1,500 mg (two 750 mg tablets) twice daily, taken after meals.

    Duration: Typically 5–7 days for acute treatment.

    Key interactions: Avoid concurrent use with sulfonamides (risk of crystalluria). CYP3A4 inhibitors (e.g., clarithromycin, ketoconazole) may alter metabolism of co-administered drugs—verify clearance windows.

    Counseling points: Take after meals. Complete full course. Report unusual diarrhea, cardiac symptoms, or rash immediately.

    Resource — no scoring impact